ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,937,000 | +47.7% | 675,469 | +13.4% | 0.01% | +40.0% |
Q3 2016 | $4,019,000 | +90.7% | 595,435 | +0.6% | 0.01% | +66.7% |
Q2 2016 | $2,107,000 | +46.5% | 591,989 | +21.4% | 0.00% | +50.0% |
Q1 2016 | $1,438,000 | -29.0% | 487,467 | +1.6% | 0.00% | -33.3% |
Q4 2015 | $2,024,000 | -7.5% | 479,611 | -0.0% | 0.00% | 0.0% |
Q3 2015 | $2,187,000 | -37.7% | 479,668 | -1.5% | 0.00% | -25.0% |
Q2 2015 | $3,512,000 | +13.9% | 487,155 | +16.5% | 0.00% | 0.0% |
Q1 2015 | $3,083,000 | +75.3% | 418,251 | +12.5% | 0.00% | +100.0% |
Q4 2014 | $1,759,000 | +30.0% | 371,942 | -1.9% | 0.00% | 0.0% |
Q3 2014 | $1,353,000 | -21.2% | 379,016 | +0.7% | 0.00% | 0.0% |
Q2 2014 | $1,717,000 | +6.5% | 376,494 | +9.7% | 0.00% | 0.0% |
Q1 2014 | $1,612,000 | -4.7% | 343,080 | +1.6% | 0.00% | -33.3% |
Q4 2013 | $1,692,000 | -17.8% | 337,804 | +2.1% | 0.00% | 0.0% |
Q3 2013 | $2,059,000 | +45.9% | 331,004 | +6.5% | 0.00% | 0.0% |
Q2 2013 | $1,411,000 | – | 310,691 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |